Research Article
Impact of Treatment with Direct Acting Antiviral Drugs on Glycemic Control in Patients with Hepatitis C and Diabetes Mellitus
Figure 2
initial and final hemoglobin A1C levels (%) in the 59 treated patients shown in Figure 1, subgrouped as to whether patients had achieved a SVR () or no SVR (). The difference between the SVR and no SVR patients was significant, as was the difference between pretreatment and posttreatment HbA1C levels in SVR patients (). SVR: sustained virologic response.